← Browse by Condition
Medical Condition
lung carcinoma
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, EARLY_Phase 1, Phase 2
NCT03582124 Phase 1, Phase 2
Recruiting
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Enrollment
30 pts
Location
United States
Sponsor
Stanford University
NCT05898594
Recruiting
Lung Cancer Screening in High-risk Black Individuals
Enrollment
900 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06645808 EARLY_Phase 1
Recruiting
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Enrollment
32 pts
Location
Netherlands
Sponsor
Var2 Pharmaceuticals
NCT07019675 Phase 2
Recruiting
A Study of SKB518 in Patients With Lung Cancer
Enrollment
192 pts
Location
China
Sponsor
Sichuan Kelun-Biotech Biopharm...
NCT06608160
Recruiting
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
Enrollment
30 pts
Location
China
Sponsor
Ruijin Hospital